OrbiMed’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $203M | Buy |
|
|||||
|
2025
Q1 | $330M | Hold |
|
|||||
|
2024
Q4 | $401M | Hold |
|
|||||
|
2024
Q3 | $401M | Hold |
|
|||||
|
2024
Q2 | $271M | Hold |
|
|||||
|
2024
Q1 | $274M | Buy |
|
|||||
|
2023
Q4 | $159M | Hold |
|
|||||
|
2023
Q3 | $83.5M | Hold |
|
|||||
|
2023
Q2 | $113M | Hold |
|
|||||
|
2023
Q1 | $97.2M | Hold |
|
|||||
|
2022
Q4 | $130M | Hold |
|
|||||
|
2022
Q3 | $143K | Buy |
|
|||||
|
2022
Q2 | $112K | Buy |
|
|||||
|
2022
Q1 | $135M | Hold |
|
|||||
|
2021
Q4 | $213M | Hold |
|
|||||
|
2021
Q3 | $231M | Hold |
|
|||||
|
2021
Q2 | $297M | Hold |
|
|||||
|
2021
Q1 | $453M | Buy |
|